Natalia Buza

15PUBLICATIONS
61CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Cancer geneticsMolecular targetsFoetal development and medicineInnate immunity
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (15)

|May 14, 2026
A Phase II Evaluation of the Efficacy and Safety of Sacituzumab Govitecan in Patients with Recurrent Uterine Cancer.

|Jan 27, 2026
Integrated mutational landscape analysis of endometrial stromal sarcoma.

Tobias M P Hartwich, Seungji Choi, Ayoung Hwang

|Aug 27, 2025
Preclinical Activity of Datopotamab Deruxtecan (Dato-DXd), an Antibody-Drug Conjugate Targeting TROP2, in Poorly Differentiated Endometrial Carcinomas.

Niccolò G Santin, Namrata Sethi, Stefania Bellone

|Jul 20, 2024
Diandric triploid partial mole versus digynic nonmolar triploidy: is morphological assessment sufficient for the diagnostic distinction?

Agnes Nagy, Na Niu, Tong Sun

|Apr 16, 2024
Integrated mutational landscape analysis of poorly differentiated high-grade neuroendocrine carcinoma of the uterine cervix.

Stefania Bellone, Kyungjo Jeong, Mari Kyllesø Halle

|Apr 09, 2024
Randomized Phase II Trial of Imiquimod with or without 9-Valent HPV Vaccine versus Observation in Patients with High-grade Pre-neoplastic Cervical Lesions (NCT02864147).

Sangini S Sheth, Ji Eun Oh, Stefania Bellone

Pageof 3

Frequent Collaborators

9 joint publications

Alessandro D Santin

6 joint publications

Pei Hui

6 joint publications

Gloria S Huang

5 joint publications

Mitchell Clark